News, infos and good to know WKN: A2QQ2E ISIN: US45256X1037 Kürzel: IBRX Forum: Aktien User: Lirumlarum1

Lesenswert!

Pancreatic cancer patients from around the world flock to Hoag Hospital for clinical trial https://www.ocregister.com/2021/06/25/pancreatic-cancer-patients-from-around-the-world-flock-to-hoag-hospital-for-clinical-trial/amp/?__twitter_impression=true

Billionaire to back cancer, Covid vaccines in SA (By Antony Sguazzin, Bloomberg 23 Sep 2021  11:51) ImmunityBio company is conducting trials of its Covid-19 vaccine in SA and has held talks with Cape Town’s Biovac Institute to potentially set up vaccine production facilities. South African-born biotech billionaire Patrick Soon-Shiong will announce a plan to transfer technology for the manufacture of Covid-19 and cancer vaccines to the African country. The California-based entrepreneur will make the announcement at 5 p.m. local time Thursday with President Cyril Ramaphosa, the South African presidency said in a statement. Soon-Shiong’s NantWorks has signed a collaboration agreement with the South African government’s Council for Scientific and Industrial Research, the South African Medical Research Council and the Centre for Epidemic Response and Innovation. Three local universities are also party to the agreement. Soon-Shiong, who has a net worth of $11 billion according to the Bloomberg Billionaires Index, was born in the South African coastal town of Gqeberha. He made his fortune after inventing cancer drug Abraxane in the US and has sold two firms for a combined $7.4 billion. His assets include the Los Angeles Times newspaper and a share of the Los Angeles Lakers basketball team. His ImmunityBio Inc. company is conducting trials of its Covid-19 vaccine in South Africa and has held talks with Cape Town’s Biovac Institute to potentially set up vaccine production facilities in the country. https://www.moneyweb.co.za/in-depth/own-your-life/billionaire-to-back-cancer-covid-vaccines-in-sa/

Upcoming Events Jefferies London Healthcare Conference NOV 16 - NOV 18, 2021 PiperSandler 33rd Annual Healthcare Conference NOV 30 - DEC 2, 2021

Unterhaltung  Tulio de Oliveira @Tuliodna So excited that we are launching the largest Genomics Facility on the African continent at CERI. Thanks, @DrPatSoonShiong @RickABright @fdesouza @RockefellerFdn @illumina @PresidencyZA to believe that Africa can lead in genomics response to epidemics . https://mobile.twitter.com/Tuliodna/status/1441115595731132419?s=19

ImmunityBio, Inc. hat retweetet Cyril Ramaphosa #VoteANC 9 Std. "Three, Dr. Soon- Shiong has identified excellent institutions with the capacity and capabilities to spread their technologies beyond our borders." https://mobile.twitter.com/immunitybio?lang=de

President Cyril Ramaphosa attends the launch announcement by Dr Soon-Shiong of NantAfrica COVID-19 https://www.youtube.com/watch?v=7LM6_OciAx4

 Presidency | South Africa  @PresidencyZA [WATCH]: President @CyrilRamaphosa is the guest of honour at an announcement of an initiative ambitious initiative to build capacity for advanced health care in Africa by Dr Patrick Soon-Shiong, founder of the multinational conglomerate, NantWorks LLC.

NantAfrica to launch ambitious COVID-19, cancer vaccine initiative https://www.sanews.gov.za/south-africa/nantafrica-launch-ambitious-covid-19-cancer-vaccine-initiative

Immunity Bio on linkedin: "Some Vaccines Last a Lifetime. Here's Why Covid-19 Shots Don't." Excellent article by Jo Craven McGinty in today's The Wall Street Journal on why some vaccines generate more immune memory than others. Note that 17 years after recovery from SARS-CoV-1 infection, patients still had reactive T-cells to the virus. B cells forget T cells remember. Click here to listen or read the full story: https://on.wsj.com/3lNf3Ny #IBRX #ImmunityBio #COVID19 #Vaccine

Adobe and Immunity Bio Blockchain Patent Applications https://www.managingrights.com/2021/05/adobe-and-immunity-bio-blockchain-patent-applications.html

Das zweite Video von oben ist wirklich sehr interessant. Hier geht er noch einmal mehr ins Detail, erklärt seine Motivation und Hindernisse und erklärt für Leihen die Funktionsweise seines T-Zellen Ansatz. Interessant war auch die Vergrößerung einer T-Zelle wie sie geziehlt Krebszellen vernichtet, oder, dass Immunity Bio ursprünglich Mitglied des Warp Speed Programms sein sollte, (zur Beschleunigung der US Impfkampagne) die Mitgliederzahl aber von 8 auf 6 verkürzt wurde und Immunitybio rausfiel.

#COVID19SA Early data from a Phase 1 clinical trial of ImmunityBio’s hAd5 T-cell COVID-19 vaccine candidate being evaluated in Cape Town has shown the jab is safe. @BrandtKev- KB https://mobile.twitter.com/ewnreporter/status/1439791776110419969?s=20

Dr Pat provides an update of his plans/progress in South Africa… https://youtu.be/aXhoHOcVK4Q

Aus einem Twitter Post könnte hervorgehen, dass IBRX mit Amyris zusammen an einem Covid Impfstoff arbeitet. https://mobile.twitter.com/ibioindex/status/1429382699815481350